[go: up one dir, main page]

WO2025118179A1 - Composition pour le soin et/ou le maquillage de matières kératiniques - Google Patents

Composition pour le soin et/ou le maquillage de matières kératiniques Download PDF

Info

Publication number
WO2025118179A1
WO2025118179A1 PCT/CN2023/136742 CN2023136742W WO2025118179A1 WO 2025118179 A1 WO2025118179 A1 WO 2025118179A1 CN 2023136742 W CN2023136742 W CN 2023136742W WO 2025118179 A1 WO2025118179 A1 WO 2025118179A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
saturated
acid
hydroxypropane
fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/CN2023/136742
Other languages
English (en)
Inventor
Feixue TENG
Xiaomin WENG
Xiaoming Wu
Qingsheng Tao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to PCT/CN2023/136742 priority Critical patent/WO2025118179A1/fr
Priority to FR2400183A priority patent/FR3156317A3/fr
Publication of WO2025118179A1 publication Critical patent/WO2025118179A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/34—Free of silicones

Definitions

  • the present invention relates to a cosmetic composition.
  • the present invention relates to a silicone-free composition.
  • the present invention also relates to a non-therapeutic method for caring for and/or making up keratin materials.
  • Different cosmetic products will comprise different cosmetic active ingredients due to the desired use.
  • Some products for caring for and/or making up keratin materials have a lamellar structure.
  • silicone-free products for caring for and/or making up keratin materials, which have good anti-soaping effect.
  • the present invention relates to a silicone-free composition, preferably caring for and/or making up keratin material, comprising:
  • At least one nonionic surfactant selected from glyceryl C14-C22 fatty acid esters, polyoxyethylenated C14-C22 fatty acid esters, alkylglucosides, and mixtures thereof;
  • At least one oil selected from alkanes, C8-C50 fatty esters, C8-C12 fatty alcohols, and mixtures thereof;
  • composition of the present invention has good anti-soaping effect.
  • the composition of the present invention has a lamellar structure.
  • the present invention relates to a non-therapeutic method for caring for and/or making up keratin materials, comprising applying the composition according to the present invention to the keratin materials.
  • Fig. 1 shows the standards for scoring the intensity of the soaping films obtained from compositions to be tested.
  • keratin materials refer to the skin and the lips.
  • skin we intend to mean all the body skin, including the scalp.
  • the keratin material is the facial skin.
  • the silicone-free composition according to the present invention comprises:
  • At least one nonionic surfactant selected from glyceryl C14-C22 fatty acid esters, polyoxyethylenated C14-C22 fatty acid esters, alkylglucosides, and mixtures thereof;
  • At least one oil selected from alkanes, C8-C50 fatty esters, C8-C12 fatty alcohols, and mixtures thereof;
  • the composition of the present invention comprises at least one saturated C14-C22 fatty acid.
  • saturated C14-C22 fatty acid mention can be made of myristic acid, pentadecanoic acid, palmitic acid, heptadecanoic acid, stearic acid, arachidic acid, behenic acid, and combinations thereof.
  • the fatty acid is selected from saturated C14-C18 fatty acids.
  • the fatty acid is selected from linear and saturated C14-C18 fatty acids.
  • the fatty acid is selected from myristic acid, palmitic acid, stearic acid, and combinations thereof.
  • the saturated C14-C22 fatty acid is present in an amount ranging from 0.5 wt. %to 30 wt. %, preferably from 1 wt. %to 10 wt. %, more preferably from 3 wt. %to 7 wt. %, relative to the total weight of the composition.
  • the composition of the present invention comprises at least one nonionic surfactant selected from glyceryl C14-C22 fatty acid esters, polyoxyethylenated C14-C22 fatty acid esters, alkylglucosides, and mixtures thereof.
  • glyceryl C14-C22 fatty acid ester means an ester of glycerol and a C14-C22 fatty acid.
  • C14-C22 fatty acid can be an unsaturated or saturated, linear or branched acid, for example, stearic acid, isostearic acid, oleic acid, palmitic acid, and/or myristic acid.
  • glyceryl C14-C22 fatty acid ester examples include glyceryl oleate, glyceryl stearate, glyceryl isostearate, glyceryl palmitate, glyceryl myristate, glyceryl arachidate, glyceryl behenate, and mixtures thereof.
  • polyoxyethylenated C14-C22 fatty acid ester is an ester of polyethylene glycol and a C14-C22 fatty acid.
  • the polyethylene glycol comprises from 1 to 200 oxyethylene groups, more preferably comprises from 10 to 150 oxyethylene groups, most preferably comprises from 20 to 100 oxyethylene groups.
  • alkylglucosides mention can be made of ethers of glucose and of C8-C24 fatty alcohols, i.e., C8-C24 alkylglucosides, for example decylglucoside, caprylyl/capryl glucoside, laurylglucoside, coco-glucoside, cetostearyl glucoside, arachidyl glucoside, or mixtures thereof.
  • C8-C24 alkylglucosides for example decylglucoside, caprylyl/capryl glucoside, laurylglucoside, coco-glucoside, cetostearyl glucoside, arachidyl glucoside, or mixtures thereof.
  • the nonionic surfactant is selected from glyceryl esters of a saturated C14-C22 fatty acid, esters of polyethylene glycol comprising from 10 to 150 oxyethylene groups and a saturated C14-C22 fatty acid, C8-C24 alkylglucosides, and combinations thereof.
  • the nonionic surfactant is selected from glyceryl stearate, glyceryl isostearate, glyceryl palmitate, glyceryl myristate, esters of polyethylene glycol comprising from 20 to 100 oxyethylene groups and a C14-C22 fatty acid selected from myristic acid, palmitic acid, stearic acid and isostearic acid, C12-C24 alkylglucosides, and combinations thereof.
  • the surfactant is selected from glyceryl stearate, PEG-100 stearate, arachidyl glucoside, and a mixture thereof.
  • composition of the present invention comprises a combination of glyceryl stearate, PEG-100 stearate, and arachidyl glucoside.
  • the nonionic surfactant is present in the composition according to the present invention in an amount ranging from 0.2 wt. %to 20 wt. %, preferably from 0.4 wt. %to 10 wt. %, more preferably from 0.8 wt. %to 5 wt. %, even more preferably from 0.8 wt. %to 3 wt. %, relative to the total weight of the composition.
  • the composition according to the present invention can have a lamellar structure, the structure can help build up the viscosity of the composition and increase the stability of the composition.
  • the weight ratio of the at least one saturated C14-C22 fatty acids to the at least one nonionic surfactant selected from glyceryl C14-C22 fatty acid ester, polyoxyethylenated C14-C22 fatty acid ester, alkylglucosides, and mixtures thereof is equal to or less than 6, preferably equal to or less than 4, more preferably from 0.2 to 4, even more preferably from 0.5 to 4, most preferably from 1 to 4.
  • the composition of the present invention comprises at least one polymer A selected from acrylic polymers.
  • the polymer A is selected from acrylic homopolymers.
  • the polymer A is selected from salts of polyacrylic acids.
  • the polymer A is selected from metal salts of polyacrylic acids.
  • the salts of polyacrylic acids can be partially or totally neutralized.
  • the polymer A is selected from sodium, potassium, lithium salts of polyacrylic acids, and mixtures thereof.
  • the most preferred salt of polyacrylic acid is sodium polyacrylate.
  • Sodium polyacrylates are acrylic homopolymers in partially or totally neutralized form, and they are hydrophilic.
  • Sodium polyacrylate is for example marketed as COVACRYL MV60 by the company SENSIENT.
  • polymer A selected from acrylic polymers is present in the composition according to the present invention in an amount ranging from 0.1 wt. %to 5 wt. %, preferably from 0.3 wt. %to 2 wt. %, more preferably from 0.5 wt. %to 1 wt. %, relative to the total weight of the composition.
  • the composition of the present invention comprises at least one oil selected from alkanes, C8-C50 fatty esters, C8-C12 fatty alcohols, and mixtures thereof.
  • oil means a water-immiscible non-aqueous compound that is liquid at room temperature (20°C) and at atmospheric pressure (760 mmHg) .
  • the oils may be volatile oils or non-volatile oils.
  • volatile oil means any oil that is capable of evaporating in contact with the skin in less than one hour, at room temperature and atmospheric pressure.
  • non-volatile refers to an oil whose vapor pressure at room temperature and atmospheric pressure is non-zero and is less than 10 -3 mmHg (0.13 Pa) .
  • alkane is intended to mean any compound comprising a linear or branched, saturated, hydrocarbon-based chain constituted exclusively of carbon atoms and hydrogen atoms.
  • the alkanes are linear or branched C 8 -C 20 alkanes. Examples that may be mentioned include hexane, undecane, dodecane, tridecane, isohexadecane, isododecane and isodecane.
  • the C8-C50 fatty ester are preferably liquid esters of saturated or unsaturated, linear or branched C 1 -C 26 aliphatic monoacids or polyacids and of saturated or unsaturated, linear or branched C 1 -C 26 aliphatic monoalcohols or polyalcohols, the total number of carbon atoms of the esters being greater than or equal to 10.
  • At least one from the alcohol and the acid, from which the esters of the present invention are derived is branched.
  • esters may be, for example, adipates, sebacates, oleates, laurates, palmitates, myristates, behenates, cocoates, stearates, linoleates, linolenates, caprates and arachidonates, or mixtures thereof.
  • the C8-C50 fatty esters are selected from diethyl sebacate, diisopropyl sebacate, bis (2-ethylhexyl) sebacate, diisopropyl adipate, di-n-propyl adipate, dioctyl adipate, bis (2-ethylhexyl) adipate, diisostearyl adipate, ethylhexyl olivate and mixture thereof; most preferably selected from diisopropyl sebacate, ethylhexyl olivate and mixture thereof.
  • the fatty alcohol is preferably selected from C8-C10 fatty alcohols, more preferably the fatty alcohol is octanol.
  • the oil is selected from branched alkanes containing from 8 to 20 carbon atoms; liquid esters of saturated or unsaturated, linear or branched C 1 -C 26 aliphatic monoacids or polyacids and of saturated or unsaturated, linear or branched C 1 -C 26 aliphatic monoalcohols or polyalcohols, the total number of carbon atoms of the esters being greater than or equal to 10; C8-C12 fatty alcohols; and mixtures thereof.
  • the oil is selected from isododecane, isohexadecane, diisopropyl sebacate, ethylhexyl olivate and mixtures thereof; even more preferably is selected from isododecane, isohexadecane, and mixtures thereof; most preferably is isododecane.
  • the oil is present in the composition of the present invention in an amount ranging from 1 wt. %to 20 wt. %, preferably from 2 wt. %to 15 wt. %, preferably from 4 wt. %to 10 wt. %, relative to the total weight of the composition.
  • composition of the present invention comprises at least one C-glycoside.
  • the C-glycoside is selected from compounds of formula (I) :
  • R represents a saturated C 1 to C 10 , preferably C 1 to C 4 , alkyl radical which can optionally be substituted by at least one radical selected from OH, COOH or COOR" 2 , with R" 2 being a saturated C 1 -C 4 alkyl radical,
  • - S represents a monosaccharide or a polysaccharide comprising up to 20 sugar units, preferably up to 6 sugar units, in pyranose and/or furanose form and of the L and/or D series, it being possible for the said monosaccharide or polysaccharide to be substituted by a hydroxyl group which is necessarily free and optionally one or more optionally protected amine functional group (s) , and
  • - X represents a radical selected from the -CO-, -CH (OH) -, -CH (NH 2 ) -, -CH (NHCH 2 CH 2 CH 2 OH) -, -CH (NHPh) -and -CH (CH 3 ) -groups and preferably a -CO-, -CH (OH) -or -CH (NH 2 ) -radical and more preferably a -CH (OH) -radical,
  • the S-CH 2 -X bond represents a bond of C-anomeric nature, which can be ⁇ or ⁇ ,
  • the C-glycoside of use for the implementation of the invention are preferably those for which R denotes a saturated linear C 1 to C 6 , preferablyC 1 to C 4 , more preferentially C 1 to C 2 , alkyl radical and even more preferably a methyl radical.
  • a monosaccharide of the invention can be selected from D-glucose, D-galactose, D-mannose, D-xylose, D-lyxose or L-fucose, L-arabinose, L-rhamnose, D-glucuronic acid, D-galacturonic acid, D-iduronic acid, N-acetyl-D-glucosamine or N-acetyl-D-galactosamine and advantageously denotes D-glucose, D-xylose, N-acetyl-D-glucosamine or L-fucose and preferablyD-xylose.
  • a polysaccharide of the invention comprising up to 6 sugar units can be selected from D-maltose, D-lactose, D-cellobiose, D-maltotriose, a disaccharide combining a uronic acid selected from D-iduronic acid or D-glucuronic acid with a hexosamine selected from D-galactosamine, D-glucosamine, N-acetyl-D-galactosamine or N-acetyl-D-glucosamine, an oligosaccharide comprising at least one xylose which can advantageously be selected from xylobiose, methyl- ⁇ -xylobioside, xylotriose, xylotetraose, xylopentaose and xylohexaose and preferably xylobiose, which is composed of two xylose molecules linked via a 1-4 bond.
  • S can represent a monosaccharide selected from D-glucose, D-xylose, L-fucose, D-galactose or D-maltose and preferably D-xylose.
  • - R denotes an unsubstituted linear C 1 -C 4 , preferablyC 1 -C 2 , alkyl radical, especially a methyl radical;
  • - S represents a monosaccharide as described above and selected preferably from D-glucose, D-xylose, N-acetyl-D-glucosamine or L-fucose, and more preferably D-xylose;
  • - X represents a group selected from -CO-, -CH (OH) -or -CH (NH 2 ) -and preferably a -CH (OH) -group.
  • the acceptable salts of the compounds described in the present invention comprise conventional non-toxic salts of the said compounds, such as those formed from organic or inorganic acids. Mention may be made, by way of example, of the salts of inorganic acids, such as sulfuric acid, hydrochloric acid. Mention may also be made of the salts of organic acids, which can comprise one or more carboxylic, sulfonic or phosphonic acid groups. Mention may be made of propionic acid, acetic acid, terephthalic acid, citric acid and tartaric acid.
  • neutralization of the acid group (s) can be carried out with an inorganic base, such as LiOH, NaOH, KOH, Ca (OH) 2 , NH 4 OH, Mg (OH) 2 or Zn (OH) 2 , or with an organic base, such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine.
  • an inorganic base such as LiOH, NaOH, KOH, Ca (OH) 2 , NH 4 OH, Mg (OH) 2 or Zn (OH) 2
  • organic base such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine.
  • This primary, secondary or tertiary alkylamine can comprise one or more nitrogen and/or oxygen atoms and can thus comprise, for example, one or more alcohol functional groups; mention may be made of 2-amino-2-methylpropanol, triethanolamine, 2- (dimethylamino) propanol or 2-amino-2- (hydroxymethyl) -1, 3-propanediol. Mention may also be made of lysine or 3- (dimethylamino) propylamine.
  • solvates which are acceptable for the compounds described in the present invention comprise conventional solvates, such as those formed during the final stage of preparation of the said compounds due to the presence of solvents. Mention may be made, by way of example, of the solvates due to the presence of water or of linear or branched alcohols, such as ethanol or isopropanol.
  • a C-glycoside corresponding to the formula (I) can be used alone or as a mixture with other C-glycoside and in any proportion.
  • a C-glycoside which is suitable for the invention can be obtained by the synthetic method described in the document WO 02/051828.
  • C- ⁇ -D-xylopyranoside-2-hydroxypropane or C- ⁇ -D-xylopyranoside-2-hydroxypropane and better still C- ⁇ -D-xylopyranoside-2-hydroxypropane can advantageously be used for the preparation of a composition according to the invention.
  • the C-glycoside can be C- ⁇ -D-xylopyranoside-2-hydroxypropane (or hydroxypropyl tetrahydropyrantriol) provided in the form of a solution containing 70%by weight of active material in water and propylene glycol.
  • the C-glycoside is present in the composition in an amount ranging from 1 wt. %to 30 %, preferably from 3 wt. %to 20 wt. %, more preferably from 5 wt. %to 15 wt. %, relative to the total weight of the composition.
  • the composition of the present invention further comprises a polymer B selected from optionally neutralized acrylic acid copolymers having a hydrophobic fatty chain with 8-40 carbon atoms.
  • a polymer B selected from optionally neutralized acrylic acid copolymers having a hydrophobic fatty chain with 8-40 carbon atoms.
  • optionally neutralized acrylic acid copolymers means the acrylic acid copolymers are optionally neutralized partially or totally with a base such as ammonia, sodium hydroxide or potassium hydroxide.
  • Polymer B is different from polymer A mentioned previously.
  • the polymer B is selected from optionally neutralized copolymers of:
  • R 1 denotes H or CH 3 or C 2 H 5 , that is to say acrylic acid or methacrylic acid or ethacrylic acid monomers respectively, and
  • R 2 denotes H or CH 3 or C 2 H 5 (that is to say, acrylate or methacrylate or ethacrylate units respectively) and preferably H (acrylate units) or CH 3 (methacrylate units) and R 3 denotes a C 10 -C 30 alkyl radical.
  • the (C 10 -C 30 ) alkyl esters of unsaturated carboxylic acids are preferably selected from lauryl acrylate, stearyl acrylate, decyl acrylate, isodecyl acrylate, dodecyl acrylate and the corresponding methacrylates, such as lauryl methacrylate, stearyl methacrylate, decyl methacrylate, isodecyl methacrylate and dodecyl methacrylate, and their mixtures.
  • the polymer B is crosslinked.
  • crosslinking agent which is a well-known copolymerizable polyethylenic unsaturated monomer, such as diallyl phthalate, allyl (meth) acrylate, divinylbenzene, (poly) ethylene glycol dimethacrylate and methylenebisacrylamide, and
  • a base selected from ammonia, sodium hydroxide, potassium hydroxide, and a combination thereof.
  • copolymers of this type of those composed of 95 wt %to 60 wt %of acrylic acid (hydrophilic unit) , 4 wt %to 40 wt %of C 10 -C 30 alkyl acrylate (hydrophobic unit) and 0 wt %to 6 wt %of crosslinking polymerizable monomer or else of those composed of 98 wt %to 96 wt %of acrylic acid (hydrophilic unit) , 1 wt %to 4 wt %of C 10 -C 30 alkyl acrylate (hydrophobic unit) and 0.1 wt %to 0.6 wt %of crosslinking polymerizable monomer, such as those described above, optionally the copolymers are neutralized partially or totally with a base such as ammonia, sodium hydroxide or potassium hydroxide.
  • a base such as ammonia, sodium hydroxide or potassium hydroxide.
  • Pemulen TM TR-1 Preference is given to the products sold by Lubrizol under the trade names Pemulen TM TR-1, Pemulen TM TR-2, Carbopol1382 and Carbopol EDT 2020.
  • the composition of the present invention comprises an optionally neutralized acrylic acid copolymer selected from sodium acrylate/C10-30 alkyl acrylate crosspolymer, acrylic acid/C10-30 alkyl acrylate crosspolymer, and a combination thereof.
  • the polymer B is present in the composition according to the present invention in an amount ranging 0.05 wt. %to 5 wt. %, preferably 0.08 wt. %to 2 wt. %, more preferably 0.1 wt. %to 1 wt. %, relative to the total weight of the composition.
  • the composition of the present invention further comprises a hydrophobic powder with a hydrophobic part comprising a C14-C30 fatty chain.
  • the hydrophobic powder is selected from mineral particles coated with a C14-C30 fatty alcohol.
  • the hydrophobic powder is selected from mineral oxide particles coated a C16-C22 fatty alcohol.
  • the composition of the present invention comprises silica coated with cetyl alcohol.
  • the hydrophobic powder is present in the composition according to the present invention in an amount ranging 0.05 wt. %to 3 wt. %, preferably 0.1 wt. %to 1.5 wt. %, more preferably 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
  • composition of the present invention comprises a continuous aqueous phase.
  • Said aqueous phase is preferably present in an amount ranging from 10 wt. %to 95 wt. %, more preferably from 20 wt. %to 90 wt. %, relative to the total weight of the composition.
  • the continuous aqueous phase comprises water.
  • Water is preferably present in the composition of the present invention in an amount ranging from 10 wt. %to 95 wt. %, preferably from 50 wt. %to 90 wt. %, relative to the total weight of the composition.
  • composition of the present invention may comprise an additional cosmetic active ingredient.
  • niacinamide As examples of additional cosmetic active ingredients, mention can be made of niacinamide, panthenol, and mixtures thereof.
  • the cosmetic composition of the present invention may also contain conventional cosmetic adjuvants or additives, for instance fragrances, preserving agents, bactericides, additional surfactants, waxes; additional thickeners, pH regulators, and mixtures thereof.
  • conventional cosmetic adjuvants or additives for instance fragrances, preserving agents, bactericides, additional surfactants, waxes; additional thickeners, pH regulators, and mixtures thereof.
  • composition according to the present invention is "silicone-free” , which means that the amount of silicone in the composition is less than 2 wt. %, relative to the total weight of the composition.
  • the amount of silicone in the composition is less than 1 wt. %, relative to the total weight of the composition.
  • the composition according to the present invention comprises no silicone.
  • the small amounts of silicone may be provided by ingredients of the composition that contain it in residual amount but are not deliberately provided.
  • the present invention provides a silicone-free composition, preferably for caring for and/or making up keratin materials, comprising, relative to the total weight of the composition:
  • composition of the present invention can be prepared with conventional means in the art.
  • composition of the present invention can be used for caring for and/or making up keratin materials.
  • the present invention relates to a non-therapeutic method for caring for and/or making up keratin materials, comprising applying the composition according to the present invention to the keratin materials.
  • the keratin material can be the skin, for example the facial skin.
  • compositions of invention examples (IE) 1-7 and comparative examples (CE) 1-2 were prepared based on the amounts given in Table 2. The amounts are given in %by weight of each ingredient relative to the total weight of the composition.
  • compositions listed above were prepared as follows:
  • Anti-soaping property of each composition was evaluated by in-vitro protocol as follows:
  • compositions of invention examples 1-7 and comparative examples 1-2 were summarized below.
  • compositions of invention examples 1-7 are anti-soaping.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition sans silicone, de préférence pour le soin et/ou le maquillage d'une matière kératinique, comprenant : (i) au moins un acide gras en C14-C22 saturé, (ii) au moins un tensioactif non ionique choisi parmi les esters d'acide gras en C14-C22 de glycéryle, les esters d'acide gras en C14-C22 polyoxyéthylénés, les alkylglucosides, et leurs mélanges ; (iii) au moins un polymère A choisi parmi les polymères acryliques ; (iv) au moins une huile choisie parmi les alcanes, les esters gras en C8-C50, les alcools gras en C8-C12, et leurs mélanges ; et (v) au moins un C-glycoside. L'invention concerne également un procédé non thérapeutique pour le soin et/ou le maquillage de matières kératiniques.
PCT/CN2023/136742 2023-12-06 2023-12-06 Composition pour le soin et/ou le maquillage de matières kératiniques Pending WO2025118179A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/CN2023/136742 WO2025118179A1 (fr) 2023-12-06 2023-12-06 Composition pour le soin et/ou le maquillage de matières kératiniques
FR2400183A FR3156317A3 (fr) 2023-12-06 2024-01-09 Composition de soin et/ou de maquillage de matières kératineuses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2023/136742 WO2025118179A1 (fr) 2023-12-06 2023-12-06 Composition pour le soin et/ou le maquillage de matières kératiniques

Publications (1)

Publication Number Publication Date
WO2025118179A1 true WO2025118179A1 (fr) 2025-06-12

Family

ID=95981369

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2023/136742 Pending WO2025118179A1 (fr) 2023-12-06 2023-12-06 Composition pour le soin et/ou le maquillage de matières kératiniques

Country Status (2)

Country Link
FR (1) FR3156317A3 (fr)
WO (1) WO2025118179A1 (fr)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022088014A1 (fr) * 2020-10-30 2022-05-05 L'oreal Composition pour soins cutanés
WO2022129469A1 (fr) * 2020-12-18 2022-06-23 L'oreal Composition comprenant des agents gélifiants aqueux, un tensioactif et de l'acide ascorbique
WO2022129403A1 (fr) * 2020-12-18 2022-06-23 L'oreal Composition comprenant des gélifiants aqueux, des tensioactifs et de l'acide ascorbique
WO2023028807A1 (fr) * 2021-08-31 2023-03-09 L'oreal Composition pour le soin et/ou le maquillage de matières kératiniques
WO2023028811A1 (fr) * 2021-08-31 2023-03-09 L'oreal Composition pour le soin des matières kératiniques
CN115996697A (zh) * 2020-06-30 2023-04-21 莱雅公司 改善渗透的化妆品组合物
WO2023076578A1 (fr) * 2021-10-31 2023-05-04 L'oreal Compositions cosmétiques comprenant des quantités élevées d'hydroxypropyl tétrahydropyrantriol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818547B1 (fr) 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115996697A (zh) * 2020-06-30 2023-04-21 莱雅公司 改善渗透的化妆品组合物
WO2022088014A1 (fr) * 2020-10-30 2022-05-05 L'oreal Composition pour soins cutanés
WO2022129469A1 (fr) * 2020-12-18 2022-06-23 L'oreal Composition comprenant des agents gélifiants aqueux, un tensioactif et de l'acide ascorbique
WO2022129403A1 (fr) * 2020-12-18 2022-06-23 L'oreal Composition comprenant des gélifiants aqueux, des tensioactifs et de l'acide ascorbique
WO2023028807A1 (fr) * 2021-08-31 2023-03-09 L'oreal Composition pour le soin et/ou le maquillage de matières kératiniques
WO2023028811A1 (fr) * 2021-08-31 2023-03-09 L'oreal Composition pour le soin des matières kératiniques
WO2023076578A1 (fr) * 2021-10-31 2023-05-04 L'oreal Compositions cosmétiques comprenant des quantités élevées d'hydroxypropyl tétrahydropyrantriol

Also Published As

Publication number Publication date
FR3156317A3 (fr) 2025-06-13

Similar Documents

Publication Publication Date Title
EP2092931B1 (fr) Préparation cosmétique pour la peau sous forme de lait à émulsion huile dans de l'eau
ES3000435T3 (en) Composition comprising at least one amps® copolymer, at least one acyl glutamic acid or a salt thereof and at least one alkyl polyglucoside
EP3086763B1 (fr) Composition cosmétique comprenant une huile, un tensioactif non ionique et un composé c-glycosidique
US8883125B2 (en) Cosmetic composition comprising a cucurbic acid compound and a blend of sulfonic and acrylic polymers
EP4262733A1 (fr) Composition comprenant des gélifiants aqueux, un tensioactif, des huiles, des charges et de l'acide ascorbique
EP2579946A2 (fr) Compositions cosmétiques aqueuses colorées
KR20190097042A (ko) 수중유형 조성물
WO2022129469A1 (fr) Composition comprenant des agents gélifiants aqueux, un tensioactif et de l'acide ascorbique
KR20200044831A (ko) 비수계용 증점제 및 증점 조성물
WO2025118179A1 (fr) Composition pour le soin et/ou le maquillage de matières kératiniques
WO2024130622A1 (fr) Composition pour le soin et/ou le maquillage de matières kératiniques
KR20190077400A (ko) 수중유형 피부 외용 조성물
TW202034890A (zh) 油中水型皮膚外用組成物
KR20210106430A (ko) 자외선 차단 효과를 갖는 수중유 유화 화장품
US20240225966A1 (en) Composition for caring for and/or making up keratin materials
JP7137924B2 (ja) 水中油乳化組成物
JP7372658B2 (ja) 液状水中油型乳化化粧料
WO2025091220A2 (fr) Composition sous forme d'émulsion huile dans l'eau
JP6835385B2 (ja) 洗浄用組成物
WO2025091239A1 (fr) Composition sous forme d'émulsion huile-dans-eau
WO2025043461A1 (fr) Composition anhydre pour le soin et/ou le maquillage de matières kératiniques
WO2016101159A1 (fr) Compositions cosmétiques de soin de la peau à rincer et procédés cosmétiques les utilisant
CN119255780A (zh) 用于护理和/或化妆角蛋白材料的组合物
JP2021187790A (ja) 化粧料
WO2016091937A1 (fr) Composition aqueuse comprenant de l'hespérétine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23960492

Country of ref document: EP

Kind code of ref document: A1